Prime Capital Investment Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.79M Sell
14,292
-2,871
-17% -$595K 0.03% 325
2026
Q1
$3.85M Buy
17,163
+497
+3% +$124K 0.04% 255
2025
Q4
$4.01M Sell
16,666
-685
-4% -$175K 0.05% 234
2025
Q3
$4.75M Buy
17,351
+759
+5% +$207K 0.06% 205
2025
Q2
$4.28M Sell
16,592
-2,348
-12% -$560K 0.06% 217
2025
Q1
$4.24M Buy
18,940
+2,471
+15% +$577K 0.05% 249
2024
Q4
$3.77M Sell
16,469
-1,357
-8% -$327K 0.05% 228
2024
Q3
$4.35M Sell
17,826
-1,185
-6% -$265K 0.06% 207
2024
Q2
$3.64M Sell
19,011
-3,270
-15% -$663K 0.05% 233
2024
Q1
$4.41M Sell
22,281
-324
-1% -$59.4K 0.06% 215
2023
Q4
$3.89M Buy
22,605
+2,092
+10% +$321K 0.06% 222
2023
Q3
$3.03M Sell
20,513
-3,897
-16% -$705K 0.06% 212
2023
Q2
$5.33M Sell
24,410
-151
-0.6% -$33.7K 0.11% 153
2023
Q1
$5.38M Buy
+24,561
New +$5.33M 0.22% 92

Other funds holding RMD

Prime Capital Investment Advisors's RMD Position: Q2 2026 in Review

Prime Capital Investment Advisors reduced its ResMed (RMD) stake by 17% in Q2 2026, selling an estimated $595K and leaving 14,292 shares worth $2.79M. The position accounts for 0.03% of the portfolio, ranked #325.

Prime Capital Investment Advisors first reported a position in RMD in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.38M in Q1 2023. 605 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Prime Capital Investment Advisors held 14,292 shares of ResMed worth $2.79M as of Q2 2026.
  • Prime Capital Investment Advisors sold 2,871 ResMed shares in Q2 2026, an estimated $595K.
  • ResMed made up 0.03% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #325 holding.
  • Prime Capital Investment Advisors first reported a position in ResMed in Q1 2023 and has held it in 14 quarters since.
  • Prime Capital Investment Advisors's ResMed position peaked at $5.38M in Q1 2023.
  • 605 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.